Pharmacy Automation Systems Market 5.8% CAGR: Top Companies in 2025 According to a newly published market research report by 24LifeSciences, the global Pharmacy Automation Systems market was valued at USD 3.06 billion in 2024 and is projected to reach USD 4.51 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 2025-2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7510/pharmacy-automation-systems-market

Hospital Acquired Infection Treatment Market to Grow at a CAGR of 1.7% Through 2032 According to a newly published market research report by 24LifeSciences, global Hospital Acquired Infection Treatment market was valued at USD 18.34 billion in 2024 and is projected to reach USD 20.62 billion by 2032, growing at a compound annual growth rate (CAGR) of 1.7% during the forecast period 2025–2032. Hospital Acquired Infections (HAIs), clinically referred to as nosocomial infections, are infections acquired by patients during the course of receiving treatment for other conditions within healthcare facilities, presenting a significant challenge to patient safety worldwide. These infections encompass a range of serious conditions including urinary tract infections, surgical site infections, bloodstream infections, and ventilator-associated pneumonia, among others. The treatment landscape is multifaceted, involving advanced antimicrobial agents, antiseptics, and specialized medical devices designed to combat these pathogens and improve patient outcomes in clinical settings. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9478/hospital-acquired-infection-treatment-market

Global Digestive Health Supplements Market Analysis & Future Opportunities According to a newly published market research report by 24LifeSciences, global digestive health supplements market was valued at USD 11.2 billion in 2024 and is projected to reach USD 19.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/14047/digestive-health-supplements-market

Monkeypox Test Kit Market Size, Share & Revenue Outlook 2032 According to a newly published market research report by 24LifeSciences, the global Monkeypox Test Kit market was valued at USD 896.2 million in 2024 and is projected to reach USD 1.54 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 20252032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13133/monkeypox-test-kit-market

Blood Bank (Blood Banking) Market Forecast 2026–2034: Trends & Insights According to a newly published market research report by 24LifeSciences, the global blood bank (blood banking) market was valued at USD 19,430 million in 2024 and is projected to reach USD 31,370 million by 2031, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6795/blood-bank-blood-banking-market

Global Doxorubicin Hydrochloride Liposome Injection Market to Reach USD 2.9 Billion by 2034 According to a newly published market research report by 24LifeSciences, the global doxorubicin hydrochloride liposome injection market was valued at USD 1.8 billion in 2025 and is projected to reach USD 2.9 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 2026–2034. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/14612/doxorubicin-hydrochloride-liposome-injection-market

Global Progressive Multifocal Leukoencephalopathy Treatment Market to Reach USD 7.2 Billion by 2032 According to a newly published market research report by 24LifeSciences, global Progressive Multifocal Leukoencephalopathy Treatment market was valued at USD 380 million in 2024 and is projected to reach USD 650 million by 2031, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 20252031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15890/progressive-multifocal-leukoencephalopathy-treatment-market

Pulmonary Drug Delivery Systems Market to Grow at a CAGR of 4.5% Through 2032 According to a newly published market research report by 24LifeSciences, global pulmonary drug delivery systems market was valued at USD 2,908 million in 2024 and is projected to reach USD 3,941 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7673/pulmonary-drug-delivery-systems-market

Modular Operation Theater Market to Grow at a CAGR of 8.9% Through 2032 According to a newly published market research report by 24LifeSciences, global modular operation theater market was valued at USD 315 million in 2024 and is projected to reach USD 564 million by 2031, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2024–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4622/modular-operation-theater-market

Secukinumab Market to Grow at a CAGR of 6.8% Through 2032 According to a newly published market research report by 24LifeSciences, global secukinumab market was valued at USD 4.5 billion in 2024 and is projected to reach USD 7.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9981/secukinumab-market